Benzalink 12 Injection contains Benzathine Penicillin G 1,200,000 IU, a long-acting antibiotic designed for treating various bacterial infections, including streptococcal pharyngitis, syphilis, and for rheumatic fever prophylaxis. Its extended-release action ensures prolonged antibacterial activity, reducing the frequency of administration and improving patient compliance.
This injectable formulation provides a consistent therapeutic effect over several weeks, allowing healthcare providers to manage infections effectively with fewer doses. Its potent bactericidal activity targets Gram-positive organisms, ensuring reliable infection control in both outpatient and inpatient settings.
For suppliers and distributors, Benzalink 12 Injection represents a high-demand essential antibiotic, widely required in hospitals, clinics, and government healthcare programs. Its consistent prescription pattern and clinical importance make it a dependable product for stockists and pharmacies, ensuring steady business growth and recurring orders.
Adding Benzalink 12 Injection to your portfolio strengthens your presence in the antibiotic and anti-infective therapy segment, offering opportunities for bulk supply, institutional tie-ups, export, and third-party manufacturing. Its essential medicine status, proven clinical efficacy, and long-acting formulation make it a profitable and strategic addition for any pharmaceutical distributor or healthcare supplier.